Previous 10 | Next 10 |
2023-04-03 08:16:44 ET OncoSec Medical ( ONCS ) -62% clinical data of the KEYNOTE-695 trial assessing TAVO EP in combination with KEYTRUDA (pembrolizumab) in patients with advanced melanoma refractory to anti-PD-1 treatment. Ascendis Pharma ( ASND ) -38% after FD...
2023-03-31 10:05:49 ET Gainers: Y-mAbs Therapeutics ( YMAB ) +43% . G Medical Innovations ( GMVD ) +41% . Palisade Bio ( PALI ) +20% . Inozyme Pharma ( INZY ) +17% . Paratek Pharmaceuticals ( PRTK ) +17% . Losers: Pyxis...
2023-03-31 08:22:14 ET Digital World Acquisition ( DWACW ) +37% . Palisade Bio ( PALI ) +30% . G Medical Innovations Holdings ( GMVD ) +19% . Pineapple Energy ( PEGY ) +19% Q4 earnings call release Metropolitan Bank Holding (...
2023-03-30 12:33:44 ET Gainers: SCYNEXIS ( SCYX ) +54% . Palisade Bio ( PALI ) +36% . Windtree Therapeutics ( WINT ) +39% . Toro ( TORO ) +34% . F45 Training ( FXLV ) +32% . Pyxis Oncology ( PYXS ) +29% . EVgo ( ...
2023-03-30 10:02:34 ET Gainers: SCYNEXIS ( SCYX ) +61% . Palisade Bio ( PALI ) +33% . Biophytis ( BPTS ) +10% . RenovoRx ( RNXT ) +9% . VYNE Therapeutics ( VYNE ) +9% . Losers: AngioDynamics ( ANGO ) -28% . ...
2023-03-30 08:44:07 ET SCYNEXIS ( SCYX ) +93% jumps 92% on licensing deal with GSK for anti-fungal agent. Freight Technologies ( FRGT ) +23% warded Whirlpool Contract. Cazoo Group ( CZOO ) +19% FY earnings call release Altus Power ( AMPS ) +...
2023-03-23 08:43:00 ET Palisade Bio press release ( NASDAQ: PALI ): FY GAAP EPS of -$16.53. As of December 31, 2022, the Company had cash, cash equivalents and restricted cash of $12.4 million. With the additional net cash proceeds of $4.7 million received in the first wee...
Phase 2 t opline dat a readout for prevention of post-surgical abdominal adhesions o n track for Q2 2023 Strong b alance s heet with sufficient cash expected to fund operations into mid-2024 Carlsbad, CA, March 23, 20...
PALISADES ANNOUNCES NEW FOUND'S INCREASED WEIGHTING BY GDXJ Canada NewsWire VANCOUVER, BC , March 15, 2023 /CNW/ - Palisades Goldcorp Ltd. (TSXV: PALI) (" Palisades " or the " Company ") today announced that New Found Gold Corp. (" New Found "), a sig...
Palisade Bio ( NASDAQ: PALI ) stock rose ~7% after the company said that the European Patent Office (EPO) will grant it a patent linked to its drug LB1148 for reducing post-surgical abdominal adhesions The EPO issued a notice of intention to grant for patent application numbe...
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...